University of Colorado

Biodesix will work with university researchers on an assay to help identify non-small cell lung cancer patients likely to respond to certain immunotherapies.

University of Colorado, Boulder, researchers sequenced soil samples from across the world to develop an atlas of bacteria living there.

This Week in PNAS

In PNAS this week: half-a-dozen Aspergillus sequenced, genetic similarities between friends and classmates, and more.

Funded by Biogen, The University of Colorado, and The Global Down Syndrome Foundation, the project will analyze genetics and other biology in 1,000 individuals with the disorder.

The Colorado Center for Personalized Medicine has allied with the tech giant as it begins to integrate genomic and clinical data.

Two new Nature Communications studies underscored the need for better genomic studies of populations of non-European ancestry.

Bison Diversity Boost

Researchers hope to increase the genetic diversity of bison in Minnesota, the Associated Press reports.

A University of Colorado School of Medicine-led team reported 23 new loci associated with vitiligo susceptibility.

The pipeline, called IMPACT, pinpointed genetic variants in lung cancer and melanoma patients and matched them to targeted drugs. 

NEW YORK (GenomeWeb News) — A research team at the University of Colorado, Boulder has received $14.6 million from the Defense Advanced Research Projects Agency to develop a system that will use microfluidics and mass spectrometry to determine how drugs and biological or chemical agents affect hu

Pages

The New York Times and ProPublica reports that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.